Vijjan, V., Mandhani, A., Kapoor, R., Dubey, D., Srivastava, A., Ansari, M. S., . . . Kumar, A. (2006). A randomized trial comparing low dose (40 or 80 mg) with standard dose (120 mg) of bacillus Calmette-Guerin for superficial bladder cancer. Wolters Kluwer Medknow Publications.
Chicago Style (17th ed.) CitationVijjan, Vivek, Anil Mandhani, Rakesh Kapoor, Deepak Dubey, Aneesh Srivastava, M S. Ansari, Pratipal Singh, and Anant Kumar. A Randomized Trial Comparing Low Dose (40 or 80 Mg) with Standard Dose (120 Mg) of Bacillus Calmette-Guerin for Superficial Bladder Cancer. Wolters Kluwer Medknow Publications, 2006.
MLA (8th ed.) CitationVijjan, Vivek, et al. A Randomized Trial Comparing Low Dose (40 or 80 Mg) with Standard Dose (120 Mg) of Bacillus Calmette-Guerin for Superficial Bladder Cancer. Wolters Kluwer Medknow Publications, 2006.